Can antiplatelet therapy after drug eluting stent become a problem?
Many clinical trials demonstrate that demonstrate drug-eluting stents (DES) can improve procedural success in patients with acute coronary syndromes, with a remarkable reduction in the rate of restenosis. On the other hand, it has been shown that stenting can also increase the rate of thrombotic com...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SEEd
2009-03-01
|
| Reeks: | Clinical Management Issues |
| Onderwerpen: | |
| Online toegang: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/556 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
